Back

Clinical outcome of patients with severe malignant pericardial effusion due to neoplastic disease undergoing percutaneous balloon pericardiotomy during COVID-19 pandemic

26 August 2022 (08:00 - 19:30)
Organised by:
Congress Presentation Part of: Pericardial disease, myocardial disease, COVID-19 Intervention and Surgery ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Emilio Alfonso Rodriguez

Hospital General de Catalunya, Barcelona (Spain)

5 More presentations in this session

Presentation thumbnail
Risk of acute myocardial infarction, stroke and thromboembolism following COVID-19 vaccination compared to testing positive for COVID-19 infection: a nationwide cohort study of 4.6 mio individuals
Mr M. Lassen (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
Apabetalone, a BET inhibitor, attenuates inflammation induced by viral RNA mimetic and reduces SARS-CoV-2 spike protein binding regardless of variants
Doctor E. Kulikowski (Calgary, CA)
Abstract Slides
Presentation thumbnail
No cardiac sequelae after COVID-19: results of the one year follow-up with echocardiography and biomarkers
Doctor M. Radvan (Brno, CZ)
Abstract Slides
Presentation thumbnail
PTX3 as a novel inflammatory biomarker in patients with myocarditis
Doctor A. Villatore (Milan, IT)
Abstract Slides
Presentation thumbnail
The burden of coronary revascularization associated with lipoprotein(a) in patients with atherosclerotic cardiovascular disease: data from the UK Biobank
Doctor P. Welsh (Glasgow, GB)
Abstract Slides

Access the full session

Session thumbnail
Pericardial disease, myocardial disease, COVID-19

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources